Bull Run

India's AI-powered stock screener for NSE & BSE. 5,000+ stocks with fundamentals and real-time analysis.

info@bullrun.co.in

Navigate

  • Home
  • Smart Screener
  • Stock Battle Arena
  • Watchlist
  • Go Premium

Tools

  • Advanced Stock Screening
  • Stock Comparison Tool
  • Personal Watchlist
  • Ask AI Assistant
  • Browse All Stocks
  • IPO GMP Tracker
  • Market News & Blog

Indices

  • All Indices
  • Nifty 50 Stocks
  • Sensex Stocks
  • Nifty Bank
  • Nifty IT
  • Nifty Pharma
  • Nifty Midcap 100

Screeners

  • Top Dividend Stocks
  • Debt Free Stocks
  • Undervalued Stocks
  • High ROE Stocks
  • Low PE Stocks
  • Top Rated Stocks
  • Large Cap Stocks
  • Compare Stocks
  • Browse by Sector

Browse Stocks by Sector

View All →
Non Banking Financial Company (NBFC)PharmaceuticalsComputers - Software & ConsultingIndustrial ProductsCivil ConstructionAuto Components & EquipmentsSpecialty ChemicalsOther Financial ServicesIT Enabled ServicesPackagingHotels & ResortsCommodity ChemicalsOther Electrical EquipmentGarments & ApparelsPaper & Paper ProductsSoftware ProductsPackaged FoodsCement & Cement ProductsSugarHeavy Electrical EquipmentHospitalEdible OilPower GenerationHealthcare Service Provider
© 2026 Bull Run. All rights reserved.
AboutBlogPrivacy PolicyTerms of Service

Disclaimer: Ratings and scores are generated algorithmically from publicly available market data for educational and informational purposes only. They do not constitute investment advice or solicitation to buy/sell securities. Bull Run is not a SEBI-registered Research Analyst or Investment Adviser.

  1. Home
  2. /
  3. Sectors
  4. /
  5. Medical Equipment & Supplies
  6. /
  7. Amkay Products Ltd
Financial RatiosPE RatioShareholdingDividendQuarterly ResultsBalance SheetProfit & LossCash Flow
HomeStocksMedical Equipment & SuppliesAmkay Products Ltd

Amkay Products Ltd Stock Price Today (NSE: AMKAY)

Amkay Products Ltd

AMKAYMedical Equipment & Supplies
₹52.00₹4.90 (8.46%)↓
As on 30 Mar 2026, 12:04 pm ISTMarket Closed

Fundamental Score

...

Amkay Products Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Amkay Products Ltd share price today is ₹52.00, down 8.46% on NSE/BSE as of 30 March 2026. Amkay Products Ltd (AMKAY) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹39.82 (Cr). The 52-week high for AMKAY share price is ₹81.99 and the 52-week low is ₹36.50. At a P/E ratio of 11.44x, AMKAY is currently trading below its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 14.79% and a debt-to-equity ratio of 0.07.

Amkay Products Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
-8.46%

Returns & Performance

Poor

ROE

14.79%
Good

ROCE

16.88%
Average

OPM (5Y)

10.07%

Div Yield

0.00%

Amkay Products Ltd Valuation Check

Excellent

P/E Ratio

11.44x
Poor

Industry P/E

47.87x
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Market Cap

39.82 (Cr)

Growth Engine

Poor

Profit Growth (Q)

7.65%
Excellent

Sales Growth (Q)

28.98%
Poor

Sales Growth (5Y)

7.77%
Poor

EPS Growth (5Y)

-55.84%
Excellent

Profit Growth (5Y)

39.33%

Balance Sheet Health

Excellent

Debt to Equity

0.07x
Excellent

Int. Coverage

12.23x

Free Cash Flow (5Y)

-7.28 (Cr)

Shareholding

Excellent

Promoter

73.44%
Poor

FII

0.00%
Poor

DII

0.00%
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

Amkay Products Share Price Analysis: ROCE-Driven Efficiency

In the Medical Equipment & Supplies sector, a critical, often overlooked, success factor is the efficient deployment of capital. Companies that maximize returns on their capital investments demonstrate superior operational capabilities and often achieve higher valuations. This analysis focuses on Amkay Products share price, currently trading at ₹60.20, with a Price-to-Earnings (PE) ratio of 11.44 and a Return on Capital Employed (ROCE) of 16.88%. This report is part of a broader, 80-parameter fundamental audit verified by Sweta Mishra.

A key metric for assessing financial health, ROCE indicates how effectively a company utilizes its capital to generate profits. Amkay Products' ROCE of 16.88% suggests relatively sound capital allocation compared to the broader market. This figure, however, should be benchmarked against its sector peers to determine relative strength. While a direct comparison requires access to the latest ROCE figures for companies like Choksi Asia, OSEL DEVICES LIMITED, and Transpact Enterprises Ltd, the 16.88% figure provides a useful starting point for investigation.

The strength of ROCE significantly impacts a company’s economic moat, its ability to maintain competitive advantages over long periods. A higher ROCE suggests efficient operations, possibly stemming from strong brand recognition, cost advantages, or switching costs. A sustained high ROCE often indicates a durable competitive edge that protects profits from competitors. In comparison to Choksi Asia, differences in ROCE might indicate varying levels of management effectiveness or differing strategic choices regarding capital investment. For example, disparities in ROCE, when viewed alongside publicly available information, could potentially reflect more conservative or aggressive reinvestment policies.

The PE ratio of 11.44 suggests that the market currently prices Amkay Products at a relatively conservative level compared to its earnings. However, understanding the sustainability of the 16.88% ROCE is crucial. Future earnings growth and the ability to maintain a high ROCE will ultimately determine the long-term trajectory of Amkay Products share price. Monitoring these metrics over time will provide insights into the company's ability to create and sustain shareholder value.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Amkay Products Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of AMKAY across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Excellent ROCE Performance (16.88%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Attractive Valuation (P/E: 11.44 vs Industry: 47.87)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Strong Revenue Growth (28.98%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Strong Profit Growth Track Record (39.33% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.07)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (12.23x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (73.44%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

3 factors identified

Weak Earnings Growth (-55.84% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Negative Free Cash Flow (₹-7.28 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Amkay Products Ltd Financial Statements

Comprehensive financial data for Amkay Products Ltd including income statement, balance sheet and cash flow

About AMKAY (Amkay Products Ltd)

Amkay Products Ltd is a dynamic player in the Indian medical equipment and supplies market, dedicated to enhancing healthcare accessibility and quality through its diverse product ...offerings. The company strategically focuses on manufacturing, assembling, and distributing essential medical devices and consumables that cater to a wide range of healthcare needs. From diagnostic tools to personal protective equipment, Amkay strives to provide reliable and cost-effective solutions for both healthcare professionals and individual consumers. With a commitment to innovation and quality assurance, Amkay Products Ltd aims to be a trusted partner in supporting a healthier India. Amkay Products boasts a comprehensive catalogue designed to meet the diverse demands of the modern healthcare landscape. Their product range encompasses items crucial for infection control, such as a variety of masks, sterilization materials, and protective apparel. Moreover, Amkay offers an array of diagnostic and monitoring equipment, empowering healthcare providers with the tools necessary for accurate assessments and patient care. The company also addresses the needs of home healthcare, providing products that enable individuals to manage their health conditions effectively in the comfort of their own homes. By consistently expanding and refining its offerings, Amkay Products Ltd strives to remain at the forefront of the medical supply industry. Driven by a vision of improving healthcare outcomes across India, Amkay Products Ltd emphasizes ethical business practices and a customer-centric approach. They maintain a strong focus on quality control throughout their manufacturing processes to ensure that all products meet stringent regulatory standards. Amkay's distribution network is strategically designed to reach a broad customer base, enabling them to deliver essential medical supplies efficiently and reliably. Through ongoing research and development, Amkay Products Ltd is committed to introducing innovative solutions that address emerging healthcare challenges and contribute to the overall well-being of the Indian population.

Company Details

Symbol:AMKAY
Industry:Medical Equipment & Supplies
Sector:Medical Equipment & Supplies
Website:https://amkayproducts.com

Key Leadership

Mr. Kashyap Pravin Mody
Chairman & MD
Mr. Hemanshu Kantilal Batavia
CFO & Whole Time Director
Ms. Krishna Rathi
Company Secretary & Compliance Officer

Latest News

Emkay sees extreme near-term volatility; says India-US trade deal key - Business Standard
Business Standard• 12/11/2025
Nifty could surge to 29,000 by 2026 as consumption revives, rates ease, Emkay Global says bet on discretio - The Economic Times
The Economic Times• 12/11/2025
'Stocks not immune to contagion': Why Emkay wants investors to stay defensive - Business Today
Business Today• 12/11/2025

AMKAY Share Price: Frequently Asked Questions

What is the current share price of Amkay Products Ltd (AMKAY)?

As of 30 Mar 2026, 12:04 pm IST, Amkay Products Ltd share price is ₹52.00. The AMKAY stock has a market capitalisation of ₹39.82 (Cr) on NSE/BSE.

Is AMKAY share price Overvalued or Undervalued?

AMKAY share price is currently trading at a P/E ratio of 11.44x, compared to the industry average of 47.87x. Based on this relative valuation, the Amkay Products Ltd stock appears to be Undervalued against its sector peers.

What is the 52-week high and low of AMKAY share price?

The 52-week high of AMKAY share price is ₹81.99 and the 52-week low is ₹36.50. These values are updated daily from NSE/BSE price data.

What factors affect the Amkay Products Ltd share price?

Key factors influencing AMKAY share price include quarterly earnings growth (Sales Growth: 28.98%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Amkay Products Ltd a good stock for long-term investment?

Amkay Products Ltd shows a 5-year Profit Growth of 39.33% and an ROE of 14.79%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.07 before investing in AMKAY shares.

How does Amkay Products Ltd compare with its industry peers?

Amkay Products Ltd competes with major peers in the Medical Equipment & Supplies. Investors should compare AMKAY share price P/E of 11.44x and ROE of 14.79% against the industry averages to determine competitive standing.

What is the P/E ratio of AMKAY and what does it mean?

AMKAY share price has a P/E ratio of 11.44x compared to the industry average of 47.87x. Investors pay ₹11 for every ₹1 of annual earnings.

How is AMKAY performing according to Bull Run's analysis?

AMKAY has a Bull Run fundamental score of 55.9/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does AMKAY belong to?

AMKAY operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting Amkay Products Ltd share price.

What is Return on Equity (ROE) and why is it important for AMKAY?

AMKAY has an ROE of 14.79%, which shows decent profitability but room for improvement. ROE measures how efficiently Amkay Products Ltd generates profits from shareholders capital.

How is AMKAY debt-to-equity ratio and what does it indicate?

AMKAY has a debt-to-equity ratio of 0.07, which indicates conservative financing with low financial risk.

What is AMKAY dividend yield and is it a good dividend stock?

AMKAY offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Amkay Products Ltd shares.

How has AMKAY share price grown over the past 5 years?

AMKAY has achieved 5-year growth rates of: Sales Growth 7.77%, Profit Growth 39.33%, and EPS Growth -55.84%.

What is the promoter holding in AMKAY and why does it matter?

Promoters hold 73.44% of AMKAY shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Amkay Products Ltd.

What is AMKAY market capitalisation category?

AMKAY has a market capitalisation of ₹40 crores, placing it in the Small-cap category.

How volatile is AMKAY stock?

AMKAY has a beta of N/A. A beta > 1 suggests the Amkay Products Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is AMKAY operating profit margin trend?

AMKAY has a 5-year average Operating Profit Margin (OPM) of 10.07%, indicating the company's operational efficiency.

How is AMKAY quarterly performance?

Recent quarterly performance shows Amkay Products Ltd YoY Sales Growth of 28.98% and YoY Profit Growth of 7.65%.

What is the institutional holding pattern in AMKAY?

AMKAY has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Amkay Products Ltd stock.

HomeScreenerBattleWatchlist

Frequently Asked Questions about Amkay Products Ltd

What is the current share price of Amkay Products Ltd?

Amkay Products Ltd (AMKAY) trades at ₹52.00 on NSE and BSE. Market cap ₹39.82 (Cr). Educational data only.

What is the P/E ratio of Amkay Products Ltd?

Amkay Products Ltd has a P/E of 11.44x vs industry average 47.87x.

What is the Bull Run score for Amkay Products Ltd?

Amkay Products Ltd has a Bull Run score of 55.9/100 based on 25+ financial parameters.

Does Amkay Products Ltd pay dividends?

Amkay Products Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Amkay Products Ltd?

Amkay Products Ltd has ROE of 14.79%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Amkay Products Ltd?

Amkay Products Ltd has debt-to-equity of 0.07.

Is Amkay Products Ltd a good investment?

Bull Run gives Amkay Products Ltd a score of 55.9/100. This is not investment advice — consult a SEBI-registered advisor.